Skip to main content
Top

International Journal of Hematology

Issue 3/2005

Content (19 Articles)

In memoriam susumu hibino, MD 1908–2005

A Tribute to the Memory of Susumu Hibino, MD

Hidehiko Saito

Dyskeratosis Congenita: A Disorder of Defective Telomere Maintenance?

Amanda J. Walne, Anna Marrone, Inderjeet Dokal

Immune Pathophysiology of Aplastic Anemia

Shinji Nakao, Xingmin Feng, Chiharu Sugimori

Neonatal Anemia Associated with Southeast Asian Ovalocytosis

Vichai Laosombat, Supaporn Dissaneevate, Malai Wongchanchailert, Benjamas Satayasevana

Cyclin D1 Gene Polymorphism and Susceptibility to Childhood Acute Lymphoblastic Leukemia in a Chinese Population

Xuwei Hou, Sili Wang, Yuling Zhou, Ziliang Xu, Yao Zou, Xiaofan Zhu, Mingzhe Han, Tianxiang Pang, Zhong Chao Han

Case Report

The Application of Molecular Analyses for Primary Granulocytic Sarcoma with a Specific Chromosomal Translocation

Naohiro Sekiguchi, Takashi Watanabe, Yukio Kobayashi, Chiho Inokuchi, Sung-Won Kim, Yukiko Yokota, Kazuki Tanimoto, Yoshihiro Matsuno, Kensei Tobinai

Arsenic Trioxide Therapy in Relapsed or Refractory Japanese Patients with Acute Promyelocytic Leukemia: Updated Outcomes of the Phase II Study and Postremission Therapies

Kazuyuki Shigeno, Kensuke Naito, Naohi Sahara, Miki Kobayashi, Satoki Nakamura, Sinya Fujisawa, Kaori Shinjo, Akihiro Takeshita, Ryuzo Ohno, Kazunori Ohnishi

Phase II Clinical Study of Cladribine in the Treatment of Hairy Cell Leukemia

Takashi Machii, Takaaki Chou, Muneou Suzuki, Yokiko Ohe, Shuichi Katagiri, Katagiri Kitano, Yoshihide Fujiyama, Tooru Izumi, Chihiro Shimazaki, Koji Nanba, Yasuo Ohashi, Teruo Kitani

Assessment of the International Prognostic Scoring System for Determining Chemotherapeutic Indications in Myelodysplastic Syndrome: Japanese Retrospective Multicenter Study

Yoshikazu Ito, Kazuma Ohyashiki, Hisamaru Hirai, Seishi Ogawa, Kinuko Mitani, Tomomitsu Hotta, Masami Bessho, Tomoki Naoe, Hideaki Mizoguchi, Takashi Uchiyama, Mitsuhiro Omine

Combination Therapy with Thalidomide, Incadronate, and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Naoya Ochiai, Noriko Yamada, Ryo Uchida, Shin-ichi Fuchida, Akira Okano, Mayumi Hatsuse, Masashi Okamoto, Eishi Ashihara, Chihiro Shimazaki

CD52 Is Not a Promising Immunotherapy Target for Most Patients with Multiple Myeloma

Jörg Westermann, Georg Maschmeyer, Antje van Lessen, Bernd Dörken, Antonio Pezzutto

Extramedullary Leukemic Relapses Following Hematopoietic Stem Cell Transplantation with Nonmyeloablative Conditioning

Guillermo J. Ruiz-Argüelles, David Gómez-Almaguer, Jorge Vela-Ojeda, Amelia Morales-Toquero, José David-Gómez-Rangel, Miriam A. García-Ruiz-Esparza, Briceida López-Martínez, Olga G. Cantú-Rodríguez, César H. Gutiérrez-Aguirre

Case Report

Cicatricial Pemphigoid of the Oropharynx after Allogeneic Stem Cell Transplantation for Relapsed Follicular Lymphoma

Yoshinobu Aisa, Takehiko Mori, Tomonori Nakazato, Rie Yamazaki, Jun Yamagami, Masayuki Amagai, Yasuo Ikeda, Shinichiro Okamoto

Letter to the Editor

Nephrotic Syndrome with Extensive Mesangiolysis as a Clinical Manifestation of Chronic Graft-versus-Host Disease (GVHD)

Keiki Kawakami, Yasuyuki Watanabe, Katsumi Mukai, Mikio Takagi, Tetsuya Murata, Tomoko Gotoh, Shigehisa Kitano

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine